Measured one way, success for peripheral vascular intervention (PVI) in the femoropopliteal arteries for patients with intermittent claudication has improved, as the need for repeat PVI appears to be ...

The primary endpoint was major adverse cardiac events (MACE), defined as a composite of cardiac death, target lesion myocardial infarction, and ischemia-driven target lesion revascularization, after ...

Self-expanding polyethylene terephthalate and polytetrafluoroethylene (PTFE)-covered stents have been shown to decrease the need for repeat procedures in the iliac artery. [33] Similar to surgical ...

IVUS image after PCI for a bifurcation LM lesion showing the minimal stent area and the maximal stent diameter. Photo Credit: Ahmed Bendary Use of intravascular imaging with IVUS to guide ...

A total of 268 patients who underwent successful DCB-based treatment for de novo LAD lesions were enrolled and compared with the 4,147 patients treated using a DES-only strategy. Table 1 presents the ...

ATLANTA -- Fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease did not result in ...

Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to late breaking research ...

NEW ORLEANS, LA—The use of intravascular imaging to guide complex PCI is associated with a significantly lower risk of target vessel failure when compared with conventional angiography, according to ...

Please provide your email address to receive an email when new articles are posted on . A novel stent for treating long coronary lesions met its primary performance goal at 1 year. The 48-mm stent was ...

Left main (LM) percutaneous coronary intervention (PCI) with routine intracoronary imaging guidance is recommended; however, its real-world effectiveness remains unclear. A total of 743 consecutive ...

LONDON -- Drug-coated balloon (DCB) angioplasty as the initial strategy for de novo coronary artery stenoses didn't measure up to stenting from the start, the REC-CAGEFREE I randomized trial showed.